Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

MgSafe · Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants

H2020Status: CLOSED1 October 201830 September 2022EU funding €3,956,399Call H2020-MSCA-ITN-2018

Biomedical imaging has gained a significant technological push and is the mainstay for diag-nosis and therapy monitoring. Still, imaging is yet not optimized for the new class of biode-gradable Mg-based implants. MgSafe addresses this point by training 15 ESRs in both, imag-ing and implant technologies. All ESRs will develop their individual Personal Learning Envi-ronment (PLE) and be trained based on the “T-skills concept” in technologies and transferable skills relevant for their career development and prepared to take over leadership positions in an area of tremendous research promises and clinical relevance where the lack for experts is severe and very well recognized.The ESRs will quantify the physical impact and suitability of a variety of modalities on Mg implants. Highly sophisticated imaging techniques (nano and µCT, MRT, PET, USPA, IR) will be developed beyond the forefront of medical device production in vivo and with in situ label-ling options to deliver non-invasively data on different time and length scales of the body reac-tion and material behavior during Mg degradation with a precision and plethora of details which is currently not available. Two Mg-alloys and CE-certified Mg-implants will be studied in rats and sheep. Dummy studies will be performed in parallel (following ASTM rules). The ob-tained multimodal imaging data will be combined with molecular biological/biochemical analy-sis, thereby increasing the information about physiological changes without using additional animals. An additional dimension will be added by the analysis of explants to obtain highest resolution chemical and material science data. All relevant biological and chemical in vivo and ex vivo data will be merged by computational 3D methods, simulations and machine learning approaches. The combination of these results will not only allow for an upscaling of the pro-cesses towards humans but will also deliver valuable data in terms of patient safety.

Consortium · 13 organisations

coordinator

HELMHOLTZ-ZENTRUM HEREON GMBH

DE · €505,577

participant

MEDIZINISCHE UNIVERSITAT GRAZ

AT · €528,414

participant

MRI. TOOLS GMBH

DE · €252,788

participant

MEDIZINISCHE HOCHSCHULE HANNOVER

DE · €252,788

participant

OSLOMET - STORBYUNIVERSITETET

NO · €292,342

participant

CONSIGLIO NAZIONALE DELLE RICERCHE

IT · €522,999

participant

POLITECHNIKA WARSZAWSKA

PL · €227,479

participant

SCANCO MEDICAL AG

CH · €281,277

participant

UNIVERSITETET I OSLO

NO · €292,342

participant

FUJIFILM SONOSITE BV

NL · €265,620

participant

SYNTELLIX AG

DE · €252,788

partner

BRI.TECH GMBH

AT

participant

GOETEBORGS UNIVERSITET

SE · €281,983

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.